Current status and needs of long-term follow-up clinics for hematopoietic cell transplant survivors: results of a nationwide survey in Japan.

[1]  H. Ogawa,et al.  High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation. , 2019, Blood advances.

[2]  Y. Kanda,et al.  Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey , 2018, Bone Marrow Transplantation.

[3]  M. Perales,et al.  ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Y. Kanda,et al.  Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease. , 2017, Biology of Blood and Marrow Transplantation.

[5]  I. Kerridge,et al.  What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  T. Tanaka,et al.  Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation , 2016, Bone Marrow Transplantation.

[7]  K. Tobinai,et al.  Cross-Sectional Patient Survey on the Need for a Long-Term Follow-up Program after Autologous Hematopoietic Cell Transplantation , 2016 .

[8]  S. Hashmi,et al.  Childhood to adult transition and long-term follow-up after blood and marrow transplantation , 2016, Bone Marrow Transplantation.

[9]  A. Tichelli,et al.  Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  K. Kawa,et al.  Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry , 2013, Bone Marrow Transplantation.

[11]  M. Aljurf,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation , 2012, Bone Marrow Transplantation.

[12]  B. Sandmaier,et al.  Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Pasquini,et al.  Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Michael Boeckh,et al.  Reduced mortality after allogeneic hematopoietic-cell transplantation. , 2010, The New England journal of medicine.

[15]  L. Robison,et al.  Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. , 2010, Blood.

[16]  M. Kondo,et al.  [Long-term follow-up of patients undergoing allogeneic hematopoietic stem cell transplantation in Japan]. , 2010, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[17]  R. Storb,et al.  Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K. Kawa,et al.  Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System , 2007, International journal of hematology.

[19]  J. Wingard,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.